Skip to main content
. 2020 Nov 10;12:207–215. doi: 10.2147/DHPS.S257009

Figure 2.

Figure 2

Number of reports of ADRs and deaths in patients exposed to eculizumab for each reporting year/quarter between 2010 and 2019.

Note: The number of ADRs includes the number of deaths. The reporting year is the fiscal year (the fiscal year is from April to March of the following year). For the second quarter of 2019, data are for the two months of July and August 2019.